Earnings Summary

Novo Nordisk A/s’s revenue jumped 21.42% since last year same period to $71311Mn in the Q3 2024. On a quarterly growth basis, Novo Nordisk A/s has generated 4.78% jump in its revenue since last 3-months.

Novo Nordisk A/s’s net profit jumped 21.46% since last year same period to $27301Mn in the Q3 2024. On a quarterly growth basis, Novo Nordisk A/s has generated 36.16% jump in its net profits since last 3-months.

Novo Nordisk A/s’s net profit margin jumped 0.03% since last year same period to 38.28% in the Q3 2024. On a quarterly growth basis, Novo Nordisk A/s has generated 29.96% jump in its net profit margins since last 3-months.

Novo Nordisk A/s’s earning per share (EPS) estimates for the current quarter stand at 0.88 - a 19.47% jump from last quarter’s estimates.

Novo Nordisk A/s’s earning per share (EPS) estimates for the current year stand at 0.88.

Novo Nordisk A/s’s earning per share (EPS) jumped 23.29% since last year same period to 0.9 in the Q3 2024. This indicates that the Novo Nordisk A/s has generated 23.29% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Novo Nordisk A/s declared 0.51 dividend per share during the earnings announcement for Q3 2024.